logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation

Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

date
18:42 07/09/2023
avatar
GMT Eight
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
China Stock
Huadian Liaoning Energy Development (600396.SH) plans to increase capital by 100 million yuan to Huadian (Liaoning) Energy Sales Co., Ltd.
HK Stock
CLOUDBREAK-B(02592) has successfully applied for patents in Japan and Europe, which will enhance and accelerate the global commercialization potential of CBT-009.
HK Stock
VEEKO INT'L (01173) released its interim performance, with a loss of HKD 40.45 million in this period, a year-on-year decrease of 16.93%.
Huadian Liaoning Energy Development (600396.SH) plans to increase capital by 100 million yuan to Huadian (Liaoning) Energy Sales Co., Ltd.
China Stock
CLOUDBREAK-B(02592) has successfully applied for patents in Japan and Europe, which will enhance and accelerate the global commercialization potential of CBT-009.
HK Stock
VEEKO INT'L (01173) released its interim performance, with a loss of HKD 40.45 million in this period, a year-on-year decrease of 16.93%.
HK Stock
RECOMMEND
Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
icon
27/11/2025
Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
icon
27/11/2025
Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
icon
27/11/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.